USPTO serial 75121001
GLOBAL
Reviewed by CopyMark Law Group
Reg. 2198827Status 710
- Filing date
- Status date
- Registration date
- Oct 20, 1998
- Examiner
- CASE, LEIGH CAROLINE
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with GLOBAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Global Pharmaceutical Corporation
Philadelphia, PA
HAYWARD, CA
Global Pharmaceutical Corporation
Philadelphia, PA
Global Pharmaceutical Corporation
Philadelphia, PA
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceuticals, namely, promethazine, for treatment of allergic reactions and for control of nausea and vomiting; chloroquine, for treatment of malaria and extraintestinal amebiasis; prednisolone, for treatment of adrenocortical insufficiency, rheumatic disorders and collagen diseases; tetracycline, for treatment of infections caused by gram-negative microorganisms; methyltestosterone, for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone such as in delayed puberty; meprobamate, for management of anxiety disorders; hydrocortisone, for replacement therapy in adrenocortical therapy and as anti-inflammatory agent in disorders of many organ systems; hyoscyamine, for adjunctive therapy in treatment of peptic ulcer and for control of gastric secretion in spastic colitis; chlordiazepoxide, for relief of anxiety and tension; piperazine, for treatment of roundworms and pinworms; pancrealipase; for treatment of chronic pancreatitis and cystic fibrosis; vitamins and nutritional supplements, namely, calcium gluconate, ferrous gluconate, shark cartilage, melatonin, collagen and fish liver oil | SECTION 8 - CANCELLED | Nov 28, 1994 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Global Pharmaceutical Corporation
- Other trademarks owned by IMPAX LABORATORIES, INC.
- Other trademarks owned by Global Pharmaceutical Corporation
- Other trademarks owned by Global Pharmaceutical Corporation
- Other trademarks in Class 005
- Similar marks named GLOBAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 23, 2009 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| May 9, 2008 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 9, 2008 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 8, 2007 | CFIT | CASE FILE IN TICRS | — |
| May 27, 2005 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 17, 2004 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| May 6, 2004 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| May 6, 2004 | PAPER RECEIVED | — | |
| Oct 20, 1998 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 27, 1998 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Aug 4, 1998 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 27, 1998 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jul 10, 1998 | IUAF | USE AMENDMENT FILED | — |
| Jun 9, 1998 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 8, 1997 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Nov 11, 1997 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 10, 1997 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 11, 1997 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 28, 1997 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 6, 1997 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 22, 1996 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 14, 1996 | DOCK | ASSIGNED TO EXAMINER | — |